Allergy and immunology


Basic research

Cardiovascular medicine

Complementary medicine and alternative therapies

Critical care / intensive care

Dentistry / oral medicine


Emergency medicine




Evidence-based medicine



Geriatric medicine / aging

Haematology / blood transfusion

Health economics

Health policy

History of medicine

Infectious diseases

Internal medicine

Laboratory medicine

Medical education

Medical informatics



Nutrition and metabolism

Obstetrics and gynaecology

Occupational and environmental medicine



Organisation of health care

Otolaryngology / head and neck surgery


Palliative care


Patient-physician relationship

Pharmacology and therapeutics

Primary care, family medicine

Psychiatry and psychotherapy


Public health

Quality of care


Rehabilitation medicine

Renal medicine

Respiratory medicine


Sexual medicine

Sports medicine

Statistics and research methods



Travel medicine


Ops! No article found. Reset filter

Response of a European surgical department to the COVID-19 crisis

Peloso A, Moeckli B, Oldani G, Triponez F, Toso C
Swiss Med Wkly. 2020;150:w20241

At first sight, surgery appears to be only peripherally affected by the COVID.19 pandemic. However, the surgical department plays a key role in the response to this crisis. This article aims to provide a blueprint for a general surgery department’s response to this current pandemic crisis and also future events of similar magnitude.

COVID-19 and Iran: swimming with hands tied!

Gharebaghi R, Heidary F
Swiss Med Wkly. 2020;150:w20242

Like many other countries around the world, Iran is contending with the COVID-19 epidemic, but with the additional burden of international sanctions on supplies of medicines and medical equipment.

Diagnostic diversity – an indicator of institutional and regional healthcare quality

Original article
Brutsche M, Rassouli F, Gallion H, Kalra S, Roger VL, Baty F
Swiss Med Wkly. 2018;148:w14691

The diagnostic diversity index can be seen as an indicator of diagnostic precision - the higher the degree of diversity, the better the diagnostic precision.

Dual use in the 21st century: emerging risks and global governance

Review article: Biomedical intelligence
Ienca M, Vayena E
Swiss Med Wkly. 2018;148:w14688

Dual use risks in the second decade of the 21st century are characterised by: diversification of dual use domains, digitalisation of potential threats, and the proliferation of actors.

A buyers’ club to improve access to hepatitis C treatment for vulnerable populations

Review article: Biomedical intelligence
Vernaz N, Calmy A, Hurst S, Jackson Y, Negro F, Perrier A, Wolff H
Swiss Med Wkly. 2018;148:w14649

High costs are an important barrier to treatment access for vulnerable and often uninsured patients with hepatitis C.

Predictors for shorter and longer length of hospital stay outliers: a retrospective case-control study of 8247 patients at a university hospital trauma department

Original article
Jentzsch T, Seifert B, Neuhaus V, Moos RM
Swiss Med Wkly. 2018;148:w14650

Providing efficient healthcare is important for hospitals. Shorter and longer length of hospital stay (LOS) outliers influence financial results and reimbursement.

The inconsistent ethical oversight of healthcare quality data in Switzerland

McLennan S, Maritz R, Shaw D, Elger B
Swiss Med Wkly. 2018;148:w14637

Further consideration needs to be given to how regulations can be revised in a way that ensures that healthcare improvement activities using the same quality data in Switzerland are not either overregulated on one side or completely without control on the other.

Accidental or intentional exposure to potentially toxic medications, natural toxins and chemicals during pregnancy: analysis of data from Tox Info Suisse

Original article
Vogel T, Lüde S, Baumgartner R, Rauber-Lüthy C, Simões-Wüst AP
Swiss Med Wkly. 2018;148:w14620

Pregnant women are daily exposed to potentially harmful agents, such as food products and household chemicals, as well as medications. Affected women and health professionals are still often unsure about how to react.

Point prevalence of healthcare-associated infections and antibiotic use in three large Swiss acute-care hospitals

Original article
Metsini A, Vazquez M, Sommerstein R, Marschall J, Voide C, Troillet N, Gardiol C, Pittet D, Zingg W, the Swissnoso network
Swiss Med Wkly. 2018;148:w14617

The current burden of healthcare-associated infections (HAIs) in Switzerland is unknown. Prevalence surveys have a long tradition in the field of infection prevention and control for measuring both HAI and antimicrobial use.

The impact of clinical trial units on the value of clinical research in Switzerland

Review article: Biomedical intelligence
von Niederhäusern B, Magnin A, Pauli-Magnus C
Swiss Med Wkly. 2018;148:w14615

A decade ago, the Swiss National Science Foundation instigated clinical trial units (CTUs) at the five university hospitals and St Gallen cantonal hospital, with the aim of improving the quality of Swiss academic clinical research projects.

Verpassen Sie keinen Artikel!